OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology and Infection is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-11-01 to 2023-11-01.)

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	898
COVID-19, SARS and MERS: are they closely related?	725
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	527
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	455
Follow-up of adults with noncritical COVID-19 two months after symptom onset	451
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	443
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	442
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China	414
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	413
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay	402
Non-specific effects of BCG vaccine on viral infections	327
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19	270
Novel SARS-CoV-2 variants: the pandemics within the pandemic	252
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	249
COVID-19 pandemic—a focused review for clinicians	249
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	248
COVID-19: don't neglect antimicrobial stewardship principles!	231
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	222
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	222
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	210
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India	208
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	201
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	195
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	195
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	192

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients	191
Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	184
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	184
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	173
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications	172
Viable SARS-CoV-2 in various specimens from COVID-19 patients	165
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study	164
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	163
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital	155
Female gender is associated with long COVID syndrome: a prospective cohort study	152
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection	141
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans	134
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	133
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	131
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	130
Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis	130
Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens	129
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	127
Validation of a commercially available SARS-CoV-2 serological immunoassay	127
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results	118
Post–COVID-19 chronic symptoms: a postinfectious entity?	114
Pathogenesis and management of fracture-related infection	114
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	113
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	113
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	111
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	110
Anosmia in COVID-19 patients	110
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	106
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	100
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China	99
Ibuprofen use and clinical outcomes in COVID-19 patients	99
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	97
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	97
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	94
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	94
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	94
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	94
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	93
Understanding the role of bacterial and fungal infection in COVID-19	93
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	90
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection	90
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study	90
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	89
Association of COVID-19 with pregnancy outcomes in health-care workers and general women	88
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study	88
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	88
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	87
Stigma at the time of the COVID-19 pandemic	86
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	86
Bloodstream infections – Standard and progress in pathogen diagnostics	85

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	84
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage	83
ESCMID COVID-19 living guidelines: drug treatment and clinical management	82
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis	81
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy	80
Neurologic manifestations associated with COVID-19: a multicentre registry	79
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort	78
Follow-up of asymptomatic patients with SARS-CoV-2 infection	78
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients	78
How to interpret and use COVID-19 serology and immunology tests	78
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study	78
Evolution of viral quasispecies during SARS-CoV-2 infection	78
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy	77
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	77
The interface between COVID-19 and bacterial healthcare-associated infections	74
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review	74
Clostridium difficile and One Health	73
How to accelerate antimicrobial susceptibility testing	73
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy	72
Review of trials currently testing treatment and prevention of COVID-19	72
Current landscape in the discovery of novel antibacterial agents	72
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre	71
Excretion of SARS-CoV-2 in human breast milk	70
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	70
Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea	70
Commercially available molecular tests for human papillomaviruses: a global overview	69
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns	69
Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients	69
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection	69
Pulmonary long-term consequences of COVID-19 infections after hospital discharge	68
Risk factors for chronic biofilm-related infection associated with implanted medical devices	68
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	68
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients	67
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection	65
Necrotizing skin and soft-tissue infections in the intensive care unit	64
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	62
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples	62
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection	61
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks	61
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review	59
Use of drones in clinical microbiology and infectious diseases: current status, challenges and barriers	59
Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital	58
How do I manage nocardiosis?	58
Trained innate immunity and resistance to Mycobacterium tuberculosis infection	56
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?	56
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort	55
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review	55
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis	54
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves	54
Machine learning in infection management using routine electronic health records: tools, techniques, and reporting of future technologies	54
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine	54
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis	53
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)	53
Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship	53
ESCMID rapid guidelines for assessment and management of long COVID	52
Intensive care management of influenza-associated pulmonary aspergillosis	52
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications	51
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients	51
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2	51
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization	51
Corticosteroid administration for viral pneumonia: COVID-19 and beyond	50
Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies	50
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy	50
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study	50
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del)	50
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	49
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	48
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	48
Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical	48
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)	48
Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics	48
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation	48
Role and value of whole genome sequencing in studying tuberculosis transmission	47
Long COVID-19—it's not over until?	47
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients	46
The impact of vaccines on heterologous adaptive immunity	46
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability	46
Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect	46
Novel coronavirus: how things are in Wuhan	46
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients	46

Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19	46
Invasive aspergillosis in patients with severe COVID-19 pneumonia	45
Digital PCR: a new technology for diagnosis of parasitic infections	45
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	45
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	45
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton	44
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum	44
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study	44
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis	44
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery	44
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis	44
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group	44
Incidence and mortality of brain abscess in Denmark: a nationwide population-based study	44
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting	43
Update on SARS-CoV-2 seroprevalence: regional and worldwide	43
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19	42
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination	42
Antibiotic use in the COVID-19 crisis in Spain	42
Serology anno 2021—fungal infections: from invasive to chronic	42
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence	42
Resurgence of pneumococcal meningitis in Europe and Northern America	41
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	40
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA	40
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review	40
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data	40
The kinetics of viral load and antibodies to SARS-CoV-2	40
Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study	40
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019	40
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives	39
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study	39
Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking	39
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial	38
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes	38
Co-infection with other respiratory pathogens in COVID-19 patients	38
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis	37
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	37
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes	37
Lower respiratory tract infection in the community: associations between viral aetiology and illness course	36
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study	35
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study	35
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study	35
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)	35
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis	35
Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system	35
The correct blood volume for paediatric blood cultures: a conundrum?	35
Saliva for molecular detection of SARS-CoV-2 in school-age children	35
Culture-independent detection systems for bloodstream infection	35
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae	34
Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study	34
Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity	34
Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection	34
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis	34
Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017	34
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community	34
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia	33
Diagnostic accuracy of tests for leprosy: a systematic review and meta-analysis	33
Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey	33
Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial	33
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression	33
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis	32
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance	32
How to start an antimicrobial stewardship programme in a hospital	32
Smartphones as mobile microbiological laboratories	32
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis	32
Quantifying the transmission of antimicrobial resistance at the human and livestock interface with genomics	32
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis	31
Image analysis and artificial intelligence in infectious disease diagnostics	31
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales	31
Dramatically improved hand hygiene performance rates at time of coronavirus pandemic	31
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2	31
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia	31
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort	31
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	31
Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19	30
When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit	30
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper	30
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonolog	30
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19	30
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance	30
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay	30
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing	29
Dynamics and predisposition of respiratory viral co-infections in children and adults	29
Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis	29
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	29
The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics	29
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	29
Advances in the therapy of bacterial bloodstream infections	29
Sample pooling for SARS-CoV-2 RT-PCR screening	29
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations	29
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	29
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?	29
How do I manage a patient with enterococcal bacteraemia?	29
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study	29
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain	28
Chronic Q fever-related complications and mortality: data from a nationwide cohort	28
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries	28
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	28
Negative pressure wound therapy for surgical site infections: a systematic review and meta-analysis of randomized controlled trials	28
Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective c	28
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort	28
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects	28
Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study	28
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	28
Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors	28
National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave	28
An update on Toscana virus distribution, genetics, medical and diagnostic aspects	27
Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey	27
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae	27
Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis	27
Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study	27
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	27
Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial	27
Not all COVID-19 pandemic waves are alike	27
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial	27
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospec	27
Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study	27
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients	27
Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study	27
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study	27
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain	27
Relative bradycardia in patients with COVID-19	27
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study	27
Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales	27
A novel approach for tuberculosis diagnosis using exosomal DNA and droplet digital PCR	27
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial	27
Performance evaluation of different strategies based on microscopy techniques, rapid diagnostic test and molecular loop-mediated isothermal amplification assay for the diagnosis of imported malaria	26
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales	26
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris	26
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	26
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis	26
Characterization of fungal microbiota on normal ocular surface of humans	26
Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach	26
Aminoglycosides for infective endocarditis: time to say goodbye?	26
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study	26
Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis	26
Microbiology of hip and knee periprosthetic joint infections: a database study	25
Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review	25
Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study	25
Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees	25
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain	25
Pretomanid for tuberculosis: a systematic review	25
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	25
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study	25
SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature	25
Sample pooling: burden or solution?	25

Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care	24
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	24
Prospective One Health genetic surveillance in Vietnam identifies distinct blaCTX-M-harbouring Escherichia coli in food-chain and human-derived samples	24
Patient care experience with utilization of isolation precautions: systematic literature review and meta-analysis	24
Elimination of hepatitis C in Europe: can WHO targets be achieved?	24
Mycobacterium tuberculosis Beijing genotype strains and unfavourable treatment outcomes: a systematic review and meta-analysis	24
Antimicrobial stewardship in the emergency department: characteristics and evidence for effectiveness of interventions	24
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis	24
Heterologous effects of vaccination and trained immunity	24
Management of infected pancreatic necrosis in the intensive care unit: a narrative review	23
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	23
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies	23
Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia	23
Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis	23
Nationwide outbreak of invasive listeriosis associated with consumption of meat products in health care facilities, Germany, 2014–2019	23
Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy	23
COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review	23
The impact of COVID-19 on community antibiotic use in Canada: an ecological study	23
Mediastinitis in the intensive care unit patient: a narrative review	23
Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii	23
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme	23
Isolation and culture of Methanobrevibacter smithii by co-culture with hydrogen-producing bacteria on agar plates	23
Rapid diagnostic tests for infectious diseases in the emergency department	23
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV	22
Changing epidemiology of invasive non-typhoid Salmonella infection: a nationwide population-based registry study	22
Usefulness of EQUAL Candida Score for predicting outcomes in patients with candidaemia: a retrospective cohort study	22
Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures?	22
Investigation of a nosocomial outbreak of coronavirus disease 2019 in a paediatric ward in South Korea: successful control by early detection and extensive contact tracing with testing	22
Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments	22
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	22
Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection	22
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update	22
Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial	22
Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex	21
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vac	21
Long-term neurologic and cognitive outcome and quality of life in adults after pneumococcal meningitis	21
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	21
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study	21
Caring for older adults during the COVID-19 pandemic	21
Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections	21
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study	21
Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii	21
COVID-19 vaccination in Israel	21
Challenges towards serologic diagnostics of emerging arboviruses	21
A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel	21
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign	21
Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study	21
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study	21
Bone and joint infections of the hand	21
Tick-borne encephalitis virus vaccination breakthrough infections in Germany: a retrospective analysis from 2001 to 2018	21
Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement	20
Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults	20
Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study	20
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study	20
Sniffing animals as a diagnostic tool in infectious diseases	20
One Health: a multifaceted concept combining diverse approaches to prevent and control antimicrobial resistance	20
The WHO essential medicines list AWaRe book: from a list to a quality improvement system	20
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)	20
FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort	20
Molecular epidemiology of Escherichia coli causing bloodstream infections in a centralized Canadian region: a population-based surveillance study	20
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations	20
Investigating infection management and antimicrobial stewardship in surgery: a qualitative study from India and South Africa	20
Optimizing antibiotic prescribing: collective approaches to managing a common-pool resource	20
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents	19
Antifungal activity of nitroxoline against Candida auris isolates	19
Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19	19
Clonal spread of macrolide-resistant Mycoplasma pneumoniae sequence type-3 and type-17 with recombination on non-P1 adhesin among children in Taiwan	19
The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children: a systematic review and meta-analysis	19
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study	19
Childhood COVID-19: a multicentre retrospective study	19
Evaluation of early clinical failure criteria for gram-negative bloodstream infections	19
Gender disparities in coronavirus disease 2019 clinical trial leadership	19
Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods	19
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273	19
PRAISE: providing a roadmap for automated infection surveillance in Europe	19
Prophylaxis for COVID-19: a systematic review	19
A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients	19
Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis	19
Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India	19
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection	19
Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants	18
Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan	18
Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences	18
Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults	18
Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak	18
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort	18
EUCAST evaluation of 21 brands of Mueller–Hinton dehydrated media for disc diffusion testing	18
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy	18
Digital microbiology	18
Unconventional diagnostic tests for Lyme borreliosis: a systematic review	18
Evaluating integrated surveillance of antimicrobial resistance: experiences from use of three evaluation tools	18
Comparative genomic analysis reveals a high prevalence of inter-species in vivo transfer of carbapenem-resistance plasmids in patients with haematological malignancies	18
More than loss of taste and smell: burning watering eyes in coronavirus disease 2019	18
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes	18
National case fatality rates of the COVID-19 pandemic	18
SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient	18
Avian influenza, a new threat to public health in Europe?	18
A prospective prediction tool for understanding Crimean–Congo haemorrhagic fever dynamics in Turkey	18
Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study	17
Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection	17
Short-course antibiotics for common infections: what do we know and where do we go from here?	17
Diagnostic accuracy of rapid nucleic acid tests for group A streptococcal pharyngitis: systematic review and meta-analysis	17
Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study	17
A simplified blood culture sampling protocol for reducing contamination and costs: a randomized controlled trial	17
Copan WASPLab automation significantly reduces incubation times and allows earlier culture readings	17
Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a randomized clinical trial	17
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria	17
Estimation of local transmissibility in the early phase of monkeypox epidemic in 2022	17
Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing	17
From genotype to antibiotic susceptibility phenotype in the order Enterobacterales: a clinical perspective	17
Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China	17
Interventions for rapid recognition and treatment of sepsis in the emergency department: a narrative review	17
Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018	17
Antibiotics: easier to start than to stop? Predictors of antimicrobial stewardship recommendation acceptance	17
Measles-related hospitalizations and associated complications in Jerusalem, 2018–2019	17
Treatment of hepatitis D: an unmet medical need	17
Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study	17
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study	17
Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting	17
The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function	17
Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples	17
Influenza increases invasive meningococcal disease risk in temperate countries	16
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents	16
Validity of surrogate endpoints assessing central venous catheter-related infection: evidence from individual- and study-level analyses	16
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria	16
Evidence for re-infection and persistent carriage of Shigella species in adult males reporting domestically acquired infection in England	16
Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity	16
Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study	16
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France	16
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study	16
Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime–avibactam due to a deletion in the blaKPC3 gene	16
A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs	16
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak—the CoNAN study	16
Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial	16
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)	16
Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: a multicentre European study	16
Invasive group B Streptococcus infections in non-pregnant adults: a retrospective study, France, 2007–2019	16
Impact of COVID-19 pandemic on tuberculosis care in India	16
Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014–2018 national laboratory surveillance	16
How does Pseudomonas aeruginosa affect the progression of bronchiectasis?	16
Awareness, acceptance, and adoption of the national digital contact tracing tool post COVID-19 lockdown among visitors to a public hospital in Singapore	16
Information technology aspects of large-scale implementation of automated surveillance of healthcare-associated infections	16
Seroprevalence of Lyme borreliosis in Finland 50 years ago	16
Zoonotic spill-over of SARS-CoV-2: mink-adapted virus in humans	16
High prevalence of heterotopic ossification in critically ill patients with severe COVID-19	16
Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in The Netherlands, 2010–2017: an observational study	16
Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria	16
Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review	16
How scientists and physicians use Twitter during a medical congress	16
Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020	15
First-generation oral antivirals against SARS-CoV-2	15
A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity	15
Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan	15
Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case–control study	15
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in asymptomatic individuals and es	15
Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case–control matched multicentre study (BACTCOVID)	15
Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review	15
Cell-free Mycobacterium tuberculosis DNA test in pleural effusion for tuberculous pleurisy: a diagnostic accuracy study	15
Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and	15
Post-discharge oral antimicrobial use among hospitalized patients across an integrated national healthcare network	15
Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus	15
Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates	15
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned	15
Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study	15
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission	15
Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample	15
Universal PCR screening for coronavirus disease 2019 in asymptomatic patients on admission	15
Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii	15
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review	15
Timing of antibiotics in septic patients: a prospective cohort study	15
The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases	15
Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections	15
A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea	15
Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningiti	15
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition	15
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial	15
Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	15
IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections	15
Impact of rapid microbial identification on clinical outcomes in bloodstream infection: the RAPIDO randomized trial	15
Portable molecular diagnostic instruments in microbiology: current status	14
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model	14
Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings	14
Influence of pH on the activity of finafloxacin against extracellular and intracellular Burkholderia thailandensis, Yersinia pseudotuberculosis and Francisella philomiragia and on its cellular pharmac	14
Clinical microbiology laboratory adaptation to COVID-19 emergency: experience at a large teaching hospital in Rome, Italy	14
The role of antibody indexes in clinical virology	14
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator	14
Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients	14
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values	14
Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients	14
Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway	14
Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis	14
Toxoplasma gondii-specific IgG avidity testing in pregnant women	14
Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms	14
Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study	14
Cost–benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin	14
Evidence-based dosing of convalescent plasma for COVID-19 in future trials	14
Hepatitis E: an expanding epidemic with a range of complications	13
Longitudinal profiling of plasma cytokines in melioidosis and their association with mortality: a prospective cohort study	13
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value	13
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain	13